Cognitive
DSIP
Also called Delta sleep-inducing peptide
per administration
It has been used in people, but no trial has settled how much or how often.
The human evidence for DSIP used the intravenous route. The draw worked out here assumes a subcutaneous injection, so the amount is not a direct read-across.
Quick start
DSIP at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 100–300 mcg per administration
- How often
- Every day
- Where
- Intravenous (clinical setting)
- Time to steady level
- ~2 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for DSIP describe 100–300 mcg per administration. Descriptive only, not a recommendation.
Cleared within minutes in plasma; human estimates are rough.
Human studies in the 1980s administered DSIP intravenously and mostly returned null results on sleep and related measures; no dose-ranging trial fixes a subcutaneous schedule, and the injected figures in circulation are community-derived, so no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 2hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- DSIP human infusion studies (1980s)Early intravenous studies of the delta sleep-inducing peptide largely failed to show a consistent effect on sleep architecture.